Mild Cognitive Impairment: A Brief Review and Suggested Clinical Algorithm (Q38173981)

30 August 2017

title

Mild Cognitive Impairment: A Brief Review and Suggested Clinical Algorithm (English)

1 reference

mild cognitive impairment

30 August 2017

main subject

1 reference

based on heuristic

inferred from title

cognitive dysfunction

1 reference

Sayantani Ghosh

1

1 reference

30 August 2017

David Libon

series ordinal

2

1 reference

30 August 2017

Carol Lippa

series ordinal

3

1 reference

30 August 2017

language of work or name

English

0 references

publication date

26 December 2013

1 reference

American Journal of Alzheimer's Disease & Other Dementias

30 August 2017

published in

1 reference

30 August 2017

volume

29

1 reference

30 August 2017

issue

4

1 reference

30 August 2017

page(s)

293-302

1 reference

Prevalence and severity of cognitive impairment with and without dementia in an elderly population

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Mild cognitive impairment: clinical characterization and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Mild cognitive impairment as a diagnostic entity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Quantification of five neuropsychological approaches to defining mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

The Mayo Clinic Study of Aging: design and sampling, participation, baseline measures and sample characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

The heterogeneity of mild cognitive impairment: a neuropsychological analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Outcomes of mild cognitive impairment by definition: a population study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Functional and cognitive criteria produce different rates of mild cognitive impairment and conversion to dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Two-year progression from mild cognitive impairment to dementia: to what extent do different definitions agree?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Mild cognitive impairment as predictor for Alzheimer's disease in clinical practice: effect of age and diagnostic criteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Mild cognitive impairment in the general population: occurrence and progression to Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Rate of progression of mild cognitive impairment to dementia--meta-analysis of 41 robust inception cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Mild cognitive impairment: ten years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Prevalence of mild cognitive impairment is higher in men. The Mayo Clinic Study of Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Risk factors for transitions from normal to mild cognitive impairment and dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Computer activities, physical exercise, aging, and mild cognitive impairment: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Impact of cardiovascular risk factors on cognitive function: the Tromsø study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Dietary patterns are associated with cognition among older people with mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Cholesterol and cognitive performance in normal controls and the influence of elective statin use after conversion to mild cognitive impairment: results in a clinical trial cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Kidney function is associated with the rate of cognitive decline in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Are empirically-derived subtypes of mild cognitive impairment consistent with conventional subtypes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

A behavioral task predicts conversion to mild cognitive impairment and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Clinical-neuroimaging characteristics of dysexecutive mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Course and etiology of dysexecutive MCI in a community sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Baseline predictors of clinical progression among patients with dysexecutive mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Is it time to separate subjective cognitive complaints from the diagnosis of mild cognitive impairment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Current concepts in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Functional deficits in patients with mild cognitive impairment: prediction of AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Predictors of progression from mild cognitive impairment to Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Behavioral symptoms in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Prevalence of neuropsychiatric symptoms and their association with functional limitations in older adults in the United States: the aging, demographics, and memory study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Donepezil delays progression to AD in MCI subjects with depressive symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Non-cognitive symptoms in mild cognitive impairment subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

A new clinical scale for the staging of dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

The Global Deterioration Scale for assessment of primary degenerative dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

The Mini-Mental State Examination: A Comprehensive Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Neuropsychological detection of the early stage of amnestic mild cognitive impairment without objective memory impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Is the geriatric depression scale a reliable screening tool for depressive symptoms in elderly patients with cognitive impairment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Validity of a novel computerized cognitive battery for mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Detection of MCI in the clinic: evaluation of the sensitivity and specificity of a computerised test battery, the Hopkins Verbal Learning Test and the MMSE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Computerized cognitive testing battery identifies mild cognitive impairment and mild dementia even in the presence of depressive symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Cerebral atrophy in mild cognitive impairment and Alzheimer disease: rates and acceleration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Measurements of medial temporal lobe atrophy for prediction of Alzheimer's disease in subjects with mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Three-dimensional Patterns of Hippocampal Atrophy in Mild Cognitive Impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Vascular and Alzheimer's disease markers independently predict brain atrophy rate in Alzheimer's Disease Neuroimaging Initiative controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Patterns of cerebral hypoperfusion in amnestic and dysexecutive MCI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Association of MRI markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality: the Framingham Offspring Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Tarot decks and PET scans: predicting the future of MCI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

FDG-PET and CSF phospho-tau for prediction of cognitive decline in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

FDG-PET measurement is more accurate than neuropsychological assessments to predict global cognitive deterioration in patients with mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Hippocampal formation glucose metabolism and volume losses in MCI and AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Comparing predictors of conversion and decline in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Amyloid PET imaging in patients with mild cognitive impairment: a 2-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [11C]PiB

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Identification of subgroups in amnestic mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Hippocampal activation in adults with mild cognitive impairment predicts subsequent cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Microstructural white matter changes, not hippocampal atrophy, detect early amnestic mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

White matter correlates of cognitive domains in normal aging with diffusion tensor imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Conversion to dementia from mild cognitive disorder: the Cache County Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

The APOE epsilon4 allele is associated with incident mild cognitive impairment among community-dwelling older persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

The apolipoprotein E epsilon4 allele and incident Alzheimer's disease in persons with mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

The deletion variant of α2b-adrenergic receptor is associated with decreased risk in Alzheimer's disease and mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Vitamin E and donepezil for the treatment of mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Efficacy of donepezil in mild cognitive impairment: a randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Safety and efficacy of galantamine in subjects with mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Regulatory authorities review use of galantamine in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Ginkgo biloba for prevention of dementia: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Effects of a diet integration with an oily emulsion of DHA-phospholipids containing melatonin and tryptophan in elderly patients suffering from mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Cognitive differences among depressed and non-depressed MCI participants: a project FRONTIER study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Early intervention for mild cognitive impairment: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Cognitive intervention programs for individuals with mild cognitive impairment: systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Efficacy of a cognitive intervention program in patients with mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Long-term observation of a multicomponent cognitive intervention in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Memory training (MT) in mild cognitive impairment (MCI) generates change in cognitive performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Physical activity for the prevention of cognitive decline: current evidence from observational and controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Aerobic fitness and multidomain cognitive function in advanced age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Physical activity improves verbal and spatial memory in older adults with probable mild cognitive impairment: a 6-month randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

The effect of walking and vitamin B supplementation on quality of life in community-dwelling adults with mild cognitive impairment: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Taking care of a loved one who has Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Burden among spousal and child caregivers of patients with mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Caregiving burden and psychiatric morbidity in spouses of persons with mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Caregiver support service needs for patients with mild cognitive impairment and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

The impact of dementia and mild memory impairment (MMI) on intimacy and sexuality in spousal relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Perceptions of Illness, coping, and well-being in persons with mild cognitive impairment and their care partners

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

Learning to live with a loved one with mild cognitive impairment: effectiveness of a waiting list controlled trial of a group intervention on significant others' sense of competence and well-being

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317513517040

21 January 2018

Identifiers

DOI

10.1177/1533317513517040

1 reference

30 August 2017

1 reference